ストックスクリーナーアプリを入手
89.83
0.74%
-0.67
アフターアワーズ：
90.00
0.17
+0.19%
Inhibrx Biosciences Inc (INBX) 最新ニュース
Two CEO-linked trusts buy 10,040 Inhibrx Biosciences (INBX) shares; no trading plan is reported. - Stock Titan
Inhibrx Biosciences stock falls 1.62 percent on October 5 - AD HOC NEWS
Form 4 Inhibrx Biosciences Inc For: 28 September By Investing.com - Investing.com Nigeria
Inhibrx Biosciences CEO Mark Lappe buys $998k in company stock - Investing.com Canada
Form 4 Inhibrx Biosciences Inc For: 28 September By Investing.com - Investing.com India
Form 4 Inhibrx Biosciences Inc For: 28 September By Investing.com - Investing.com UK
Four purchases over two days: Inhibrx Biosciences (INBX) CEO's family trust bought 10,000 shares. - Stock Titan
Inhibrx Biosciences CEO Mark Lappe buys $998k in company stock - Investing.com
Inhibrx Biosciences director Jon Kayyem buys $500,000 in common stock By Investing.com - Investing.com Nigeria
Form 4 Inhibrx Biosciences Inc For: 23 September - Investing.com India
Inhibrx Biosciences director Jon Kayyem buys $500,000 in common stock - Investing.com India
Form 4 Inhibrx Biosciences Inc For: 23 September By Investing.com - Investing.com UK
At $100 a share, a director's family trust bought 5,000 shares of Inhibrx Biosciences (INBX). - Stock Titan
Inhibrx Biosciences Director Kristiina Vuori Receives Corrected Stock Option Grant - Kalkine Media
Inhibrx Biosciences Director Kimberly Manhard Revises Stock Option Grant Filing - Kalkine Media
Director at Inhibrx (NASDAQ: INBX) awarded 10,000 options - Stock Titan
Inhibrx (NASDAQ: INBX) director gets 10,000 options expiring 2036 - Stock Titan
Inhibrx (INBX) corrects director's 10,000-option grant - Stock Titan
Inhibrx (INBX) corrects 10,000-option grant to director - Stock Titan
Inhibrx Biosciences director Jon Kayyem buys $500,000 in stock - Investing.com
Family trust of Inhibrx (INBX) director adds 5,000 shares at $100 - Stock Titan
Director’s trust sells 1,500 Inhibrx (INBX) shares - Stock Titan
Director’s trust at Inhibrx (NASDAQ: INBX) logs four 500-share stock sales - Stock Titan
Inhibrx (NASDAQ: INBX) director's trust files to sell 500 shares - Stock Titan
Founder of Inhibrx Biosciences Mark Lappe Buys 2.7% More Shares - webull.com
Inhibrx Biosciences director Kimberly Manhard sells $115,467 in stock By Investing.com - Investing.com South Africa
Director trust at Inhibrx (INBX) proposes $55.9K stock sale - Stock Titan
Inhibrx Biosciences director Kimberly Manhard sells $115,467 in stock By Investing.com - Investing.com Australia
Inhibrx Biosciences director Kimberly Manhard sells $115,467 in stock By Investing.com - Investing.com UK
Inhibrx Biosciences director Kimberly Manhard sells $115,467 in stock - Investing.com
Inhibrx Biosciences Director Kimberly Manhard Sells 1,000 Shares via Revocable Trust in September 2026 - Kalkine Media
Director’s trust at Inhibrx Biosciences (INBX) sells 1,000 shares in two days - Stock Titan
Analysts Offer Insights on NA Companies: Evommune, Inc. (EVMN), Inhibrx Biosciences Inc (INBX) and Circle Internet Group, Inc. Class A (CRCL) - The Globe and Mail
Founder of Inhibrx Biosciences Mark Lappe Buys 2.7% More Shares - simplywall.st
Founder of Inhibrx Biosciences Mark Lappe Buys 2.7% More Shares - simplywall.st
Inhibrx director Jon Kayyem buys $567,580 in company stock By Investing.com - Investing.com South Africa
Director-linked trust plans $57.9K INBX stock sale - Stock Titan
Inhibrx, Eikon rise after insider buying - TradingView
H.C. Wainwright reiterates Inhibrx Biosciences stock rating at buy - Investing.com
H.C. Wainwright reiterates Inhibrx Biosciences stock rating at buy By Investing.com - Investing.com Canada
Inhibrx: Market's Lukewarm Response To Yesterday's HNSCC Data Hard To Fathom (NASDAQ:INBX) - Seeking Alpha
Inhibrx director Jon Kayyem buys $567,580 in company stock By Investing.com - Investing.com Australia
Inhibrx director Jon Kayyem buys $567,580 in company stock By Investing.com - Investing.com Canada
Inhibrx (INBX) investor files notice to sell 500 shares - Stock Titan
Family trust tied to Inhibrx (INBX) director buys more stock in open market - Stock Titan
Inhibrx Biosciences reports strong Phase 2 INBRX-106 data - TipRanks
Inhibrx (INBX) director buys 2,500 shares via family trust - Stock Titan
Inhibrx Biosciences (INBX) chief boosts stake with 25,000-share buy - Stock Titan
80% response in HPV+ head and neck cancer lifts Inhibrx (INBX) trial plans - Stock Titan
Why Inhibrx Biosciences (INBX) Stock Is Down Today - Quiver Quantitative
3.29%
大文字化:
|
ボリューム (24 時間):